FWG Holdings’s Bristol-Myers Squibb BMY Stock Holding History

FWG Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,797	Closed	-$201K	–	88
2022 Q4	$201K	Buy	+2,797	New	+$211K	0.14%	82
2022 Q3	–	Sell	-2,899	Closed	-$223K	–	88
2022 Q2	$223K	Buy	2,899 +2	+0.1%	+$152	0.19%	80
2022 Q1	$212K	Sell	2,897 -265	-8%	-$17.8K	0.16%	88
2021 Q4	$212K	Buy	+3,162	New	+$185K	0.16%	90
2021 Q3	–	Sell	-3,201	Closed	-$214K	–	87
2021 Q2	$214K	Buy	+3,201	New	+$209K	0.19%	81

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FWG Holdings's BMY Position: Q1 2023 in Review

FWG Holdings sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 2,797 shares — an estimated $201K sold.

FWG Holdings first reported a position in BMY in Q2 2021 and held it in 5 quarters. The position peaked at $223K in Q2 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

FWG Holdings reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
FWG Holdings sold 2,797 Bristol-Myers Squibb shares in Q1 2023, an estimated $201K.
FWG Holdings first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 5 quarters.
FWG Holdings's Bristol-Myers Squibb position peaked at $223K in Q2 2022.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on FWG Holdings's 13F filing for Q1 2023, filed 12 May 2023.